Endpoints News
healthLeft
#ESC26: AstraZeneca's relaxin pill shows promise in mid-stage heart failure trialtranslating…
MUNICH — AstraZeneca’s oral relaxin agonist was able to improve cardiac function in some, though not all, patients in a mid-stage trial. While the study was only a partial success, this is still a decent showing ...
Keywords#AstraZeneca's#ESC26#mid-stage#relaxin#trial